University Medicine Essen Medical Scientist Academy - UMESciA
Save the DateUMEA Scientific Retreat
29.-30.08.2025
Save the DateEKFS Network Symposium
23.-24.03.2026
ETOS Prize Grubenlampe for UMESCIA Scholar Nalini Kolar Srinivas
The Essen Translational Oncology Symposium (ETOS) is an event hosted by the DKTK partner site Essen/Düsseldorf to present scientific preclinical translational and reverse translational projects. At this year's ETOS 2025 symposium, UMESCIA Scholar Nalini Kolar Srinivas received the "Grubenlampe" award for the best presentation. The "Grubenlampe," a traditional symbol of the miner's lamp used to light the way underground, is passed on each year to the next awardee. The "Grubenlampe" symbolizes how science illuminates through the acquisition of knowledge and how this light is passed on from one scientist to the next.
From left to right: Phyllis Cheung (ETOS chair), Nalini Kolar Srinivas (Winner and UMESCIA Scholar) and Sven Brandau (UMESCIA chair)
University Medicine Essen (UME) Medical Scientist Academy (UMESciA) has identified the strong need to better facilitate and foster interdisciplinary research in university medicine. The complexity of innovative therapies together with rapid technological advances in patient care require intimately interacting Medical and Clinician Scientists. To achieve this goal a supporting structural and organizational basis is also urgently needed. UMESciA will create this institutional basis by supporting “tandem research units” (TRUs) that connect distinguished Medical Scientists with Clinician Scientists from existing UME programs. UMESciA aims to provide a best practice model for German University Medicine by acting within the internationally recognized UME focus research areas of Oncology and Immunology and by building on a strong translational expertise in investigator-initiated trials (IITs). To this end, the planned Medical Scientist Academy will be integrated into existing structures of clinical excellence in oncology and will synergize with Clinician Scientist programs to generate a group of dedicated researchers that envision a career at the interface of natural sciences and medicine. The planned research program will exploit material and patient data from a large number of innovative IITs with the aim to rapidly improve patient selection and biomarker discovery in costly biological therapies of cancer.
Co-applicants:
Prof. Dr. rer. nat. Anke Hinney
Prof. Dr. med. Dirk Schadendorf
Prof. Dr. med. Selma Ugurel
UMESciA is initially funded by the Else Kröner-Fresenius-Stiftung.
